0
Signin
countryflagUS

18889881171

AAPL 169.89 0.5147% MSFT 399.04 -2.4495% GOOG 157.95 -1.9553% GOOGL 156.0 -1.9669% AMZN 173.67 -1.6535% NVDA 826.32 3.7087% META 441.38 -10.5613% TSLA 170.18 4.9652% TSM 136.58 2.7149% LLY 724.87 -1.0011% V 275.16 0.0509% AVGO 1294.42 2.9917% JPM 193.37 0.1502% UNH 493.86 1.3462% NVO 125.79 -0.2933% WMT 60.21 0.5679% LVMUY 167.91 -2.1618% XOM 121.35 0.2478% LVMHF 837.0 -2.6461% MA 462.11 -0.0843%

HCA Holdings Inc

Healthcare US HCA

314.12USD
-4.9(1.54%)

Last update at 2024-04-25T20:10:00Z

Day Range

312.13322.26
LowHigh

52 Week Range

215.47303.47
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 8580.00M 9833.00M 5430.00M 5244.00M 5335.00M
Minority interest -1191.00000M -765.00000M 633.00M 640.00M 602.00M
Net income 5643.00M 6956.00M 3754.00M 3505.00M 3787.00M
Selling general administrative 27685.00M 26779.00M 23874.00M 23560.00M 21425.00M
Selling and marketing expenses - - - - -
Gross profit 50862.00M 49271.00M 43164.00M 42855.00M 38953.00M
Reconciled depreciation 2969.00M 2853.00M 2721.00M 2596.00M 2278.00M
Ebit 9098.00M 9791.00M 7316.00M 7261.00M 6671.00M
Ebitda 12067.00M 12644.00M 10037.00M 9857.00M 8949.00M
Depreciation and amortization 2969.00M 2853.00M 2721.00M 2596.00M 2278.00M
Non operating income net other 1268.00M 1721.00M -248.00000M -150.00000M 448.00M
Operating income 9098.00M 9791.00M 7316.00M 7261.00M 6642.00M
Other operating expenses 51180.00M 49074.00M 44271.00M 44118.00M 40035.00M
Interest expense 1741.00M 1566.00M 1584.00M 1824.00M 1755.00M
Tax provision 1746.00M 2112.00M 1043.00M 1099.00M 946.00M
Interest income 1696.00M 1453.00M 1530.00M 1781.00M 1726.00M
Net interest income -1741.00000M -1566.00000M -1584.00000M -1824.00000M -1755.00000M
Extraordinary items - - - - 551.00M
Non recurring - - - - -
Other items - - - - -
Income tax expense 1746.00M 2112.00M 1043.00M 1099.00M 946.00M
Total revenue 60233.00M 58752.00M 51533.00M 51336.00M 46677.00M
Total operating expenses 41809.00M 39593.00M 35902.00M 35637.00M 32311.00M
Cost of revenue 9371.00M 9481.00M 8369.00M 8481.00M 7724.00M
Total other income expense net -518.00000M 42.00M -1886.00000M -2017.00000M 448.00M
Discontinued operations - - - - -
Net income from continuing ops 6834.00M 7721.00M 4387.00M 4145.00M 4389.00M
Net income applicable to common shares 5643.00M 6956.00M 3754.00M 3505.00M 3787.00M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 52438.00M 50742.00M 47490.00M 45058.00M 39207.00M
Intangible assets 9653.00M 9540.00M 8578.00M 8269.00M 7953.00M
Earning assets - - - - -
Other current assets 1776.00M 2010.00M 1464.00M 1346.00M 1190.00M
Total liab 52511.00M 49253.00M 44598.00M 45623.00M 42125.00M
Total stockholder equity -2767.00000M -933.00000M 572.00M -2808.00000M -4950.00000M
Deferred long term liab - - - - -
Other current liab 5293.00M 5234.00M 4960.00M 4707.00M 3896.00M
Common stock 3.00M 3.00M 3.00M 3.00M 3.00M
Capital stock 3.00M 3.00M 3.00M 3.00M 3.00M
Retained earnings -2280.00000M -532.00000M 777.00M -2351.00000M -4572.00000M
Other liab 3143.00M 3574.00M 3426.00M 2783.00M 2460.00M
Good will 9653.00M 9540.00M 8578.00M 8269.00M 7953.00M
Other assets 298.00M 598.00M 546.00M 480.00M 690.00M
Cash 908.00M 1451.00M 1793.00M 621.00M 502.00M
Cash and equivalents 908.00M 1451.00M 1793.00M 621.00M 502.00M
Total current liabilities 9902.00M 9582.00M 8704.00M 7757.00M 7569.00M
Current deferred revenue - - - - 308.00M
Net debt 38928.00M 34883.00M 30884.00M 34600.00M 32319.00M
Short term debt 370.00M 237.00M 209.00M 145.00M 788.00M
Short long term debt 370.00M 237.00M 209.00M 145.00M 788.00M
Short long term debt total 39836.00M 36334.00M 32677.00M 35221.00M 32821.00M
Other stockholder equity 2767.00M 933.00M 294.00M 2243.00M 2032.00M
Property plant equipment 27640.00M 26176.00M 23199.00M 22715.00M 19757.00M
Total current assets 13643.00M 13542.00M 12333.00M 11196.00M 10213.00M
Long term investments 1204.00M 886.00M 810.00M 564.00M 594.00M
Net tangible assets -10668.00000M -10473.00000M -6333.00000M -9578.00000M -12903.00000M
Short term investments 381.00M 438.00M 388.00M 147.00M 47.00M
Net receivables 8891.00M 8095.00M 7051.00M 7380.00M 6789.00M
Long term debt 37714.00M 34342.00M 30795.00M 33577.00M 32033.00M
Inventory 2068.00M 1986.00M 2025.00M 1849.00M 1732.00M
Accounts payable 4239.00M 4111.00M 3535.00M 2905.00M 2577.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity 2694.00M 2422.00M 2320.00M 2243.00M 2032.00M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -490.00000M -404.00000M -502.00000M -460.00000M -381.00000M
Additional paid in capital - - - - -
Common stock total equity 3.00M 3.00M 3.00M 3.00M 3.00M
Preferred stock total equity - - - - -
Retained earnings total equity -2280.00000M -532.00000M 777.00M -2351.00000M -4572.00000M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 298.00M 598.00M 546.00M 480.00M 690.00M
Deferred long term asset charges - - - - -
Non current assets total 38795.00M 37200.00M 35157.00M 33862.00M 28994.00M
Capital lease obligations 1752.00M 1755.00M 1673.00M 1849.00M -
Long term debt total 37714.00M 34342.00M 30795.00M 33577.00M 32033.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -3389.00000M -117.00000M -588.00000M -1657.00000M -1196.00000M
Change to liabilities -296.00000M 999.00M 1255.00M 396.00M 698.00M
Total cashflows from investing activities -3389.00000M -2643.00000M -3393.00000M -5720.00000M -3901.00000M
Net borrowings 3234.00M 3255.00M -3252.00000M 494.00M -369.00000M
Total cash from financing activities -5656.00000M -6655.00000M -4677.00000M -1771.00000M -3075.00000M
Change to operating activities - - - - -
Net income 6834.00M 7721.00M 4387.00M 4145.00M 4389.00M
Change in cash -543.00000M -342.00000M 1172.00M 119.00M -230.00000M
Begin period cash flow 1451.00M 1793.00M 621.00M 502.00M 732.00M
End period cash flow 908.00M 1451.00M 1793.00M 621.00M 502.00M
Total cash from operating activities 8522.00M 8959.00M 9232.00M 7602.00M 6761.00M
Issuance of capital stock - - - - -
Depreciation 2969.00M 2853.00M 2721.00M 2596.00M 2278.00M
Other cashflows from investing activities 1006.00M -4.00000M 30.00M 95.00M 868.00M
Dividends paid -653.00000M -624.00000M -153.00000M -550.00000M 487.00M
Change to inventory -59.00000M -540.00000M -304.00000M -158.00000M -242.00000M
Change to account receivables -797.00000M -962.00000M 327.00M -326.00000M -423.00000M
Sale purchase of stock -7000.00000M -8215.00000M -441.00000M -1031.00000M -1530.00000M
Other cashflows from financing activities 4827.00M -1071.00000M -866.00000M -757.00000M -714.00000M
Change to netincome -158.00000M -374.00000M 816.00M 919.00M 30.00M
Capital expenditures 4395.00M 3577.00M 2835.00M 4158.00M 3573.00M
Change receivables -797.00000M -962.00000M 327.00M -326.00000M -423.00000M
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes -523.00000M -339.00000M 1162.00M 111.00M -215.00000M
Change in working capital -1152.00000M -503.00000M 1278.00M -88.00000M 33.00M
Stock based compensation 341.00M 440.00M 362.00M 347.00M 268.00M
Other non cash items -1041.00000M -1482.00000M 443.00M 352.00M -281.00000M
Free cash flow 4127.00M 5382.00M 6397.00M 3444.00M 3188.00M

Fundamentals

  • Previous Close 319.02
  • Market Cap71513.66M
  • Volume1565918
  • P/E Ratio13.19
  • Dividend Yield0.90%
  • EBITDA12277.00M
  • Revenue TTM63162.00M
  • Revenue Per Share TTM229.02
  • Gross Profit TTM 23177.00M
  • Diluted EPS TTM20.25

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
HCA
HCA Holdings Inc		 -4.9 1.54% 314.12 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 -0.02 0.27% 7.37 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA		 -1.26 4.51% 26.65 16.76 9.62 0.42 0.79 0.78 5.31
JDHIY
JD Health International Inc		 - -% 3.42 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc		 - -% 3.03 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

HCA Holdings Inc

One Park Plaza, Nashville, TN, United States, 37203

Key Executives

Name Title Year Born
Mr. Samuel N. Hazen CEO & Director 1960
Mr. William B. Rutherford Exec. VP & CFO 1964
Mr. Charles J. Hall Pres of National Group 1953
Mr. Jon Mack Foster Pres of American Group 1962
Dr. Michael S. Cuffe M.B.A., M.D. Exec. VP & Chief Clinical Officer 1966
Dr. Thomas F. Frist Jr. Founder & Chairman Emeritus 1939
Mr. P. Martin Paslick Sr. VP & Chief Information Officer 1960
Mr. Frank George Morgan C.F.A. VP of Investor Relations NA
Ms. Kathleen M. Whalen J.D. Sr. VP and Chief Ethics & Compliance Officer 1965
Mr. Michael R. McAlevey Sr. VP & Chief Legal Officer 1964

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).